Cervical Ripening
61
5
7
35
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.9%
3 terminated out of 61 trials
92.1%
+5.6% vs benchmark
38%
23 trials in Phase 3/4
29%
10 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (61)
Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction
Safety and Usability of the Inga Catheter for Labor Induction (INGA-MDP)
Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy
Membrane Stripping for Cervical Ripening
Evaluation of the INGA Sensor System for Fetal and Uterine Monitoring During Cervical Ripening
PGE2 Followed by Oxytocin vs Oxytocin in Term PROM (POXY-PROM)
Combined Nipple Stimulation and Foley Balloon for Cervical Ripening
Latent Phase Membrane Stripping for Caesarean Section Reduction
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening
Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
The SWEEP Trial: a Randomized Controlled Trial
Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
Heated Saline in Cervical Balloon for Labor Induction, a RCT
Significance of Misoprostol-induced Cervical Ripening Prior to Hysteroscopy
Effects of Acupuncture in Spontaneous Rapture of Membranes: Applicability and Effectiveness
Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (Propess®), to Promote Induction of Labor of Pregnant Women at Term?
Patient Satisfaction During Artificial Induction of Labor by Cervical Ripening
Cervical Ripening With Cook Catheter Plus Low Dose Oxytocin
General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)